Should I buy CNNX stock in 2025?

Why trust HelloSafe?

At HelloSafe, our expert has been monitoring the performance of CNNX for more than three years. Every month, hundreds of thousands of users in Canada rely on us to interpret market trends and highlight the best investment opportunities. Our analyses are provided for informational purposes only and do not represent investment advice. In line with our ethical charter, we have never received, and will never receive, any compensation from CNNX.

What is CNNX?

How much is CNNX stock?

The price of CNNX stock is rising this week. As of now, the current share price stands at $0.0030 USD, reflecting a 24-hour increase of +3.45%. The market capitalization is approximately $3.42 million, with an average three-month trading volume of 1.57 million shares.

The company does not report a P/E ratio due to unprofitability and pays no dividend; its stock beta is 1.18, indicating volatility in line with the broader market.

Given its recent price movements and market activity, CNNX stock remains a dynamic choice, but investors should be mindful of heightened volatility in the Canadian cannabis sector.

Our full analysis on CNNX stock

Having thoroughly reviewed CNNX’s (now 4Front Ventures Corp., CSE: FFNT) latest financial disclosures and analyzed the stock’s multi-year performance, we combined proprietary algorithms leveraging fundamental indicators, technical signals, and competitive intelligence to distill market sentiment. In the context of the evolving U.S. cannabis industry and intensifying operational progress, one crucial question emerges for forward-looking investors: could CNNX stock once again represent a compelling strategic entry point into the dynamic North American cannabis sector in 2025?

Recent Performance and Market Context

Over the past twelve months, CNNX’s share price dynamics have captured considerable attention—markedly so following its rebranding as 4Front Ventures. The stock currently trades at US$0.0030, reflecting a substantial pullback of -96.59% year-on-year, and a 92.31% decline over the latest six months. However, these declines have brought the stock to its 52-week lows, with the latest 24-hour move showing a modest uptick of +3.45%. Such levels are often indicative of a bottoming process, where downside risk is increasingly reflected in the valuation.

Notably, the period has also seen several positive operational developments: the commissioning of a new 250,000 square foot facility in Matteson, Illinois, and expansions in product capacity across multiple states. Despite sector-wide volatility, the macro backdrop for the U.S. cannabis industry remains fundamentally positive, with regulatory momentum growing and state-level legislation opening new avenues. Emerging retail and wholesale opportunities—especially in growth engines like Illinois and Massachusetts—suggest a recovery scenario as efficiencies and output improvements are capitalized on by the company.

For Canadian investors, the U.S. cannabis landscape continues to distinguish itself through rapid policy advances and latent market demand. In volatile phases, the best purchase opportunities often emerge for companies demonstrating adaptation and innovation, as seems evident in CNNX’s recent narrative.

Technical Analysis

The current technical configuration of CNNX offers promising entry signals for traders and investors alike. The 14-day Relative Strength Index (RSI) is approximately 37, firmly in oversold territory. Statistically, readings below 40-45 are often associated with the early stages of bottoming, suggesting potential for market reversion as sellers exhaust their momentum.

Additionally, while the MACD remains modestly negative (>-0.01), it signals compression and declining bearish momentum—classic precursors to technical stabilization or reversal. The absence of extreme bearish “death cross” or bullish “golden cross” formations further underlines a context of neutral-to-improving sentiment rather than pronounced distress.

Importantly, the stock is currently consolidating near robust historical support between US$0.0019 and US$0.0030—a zone where previous downside moves have been absorbed and from which prior rebounds have originated. With average daily trading volume steady at 1.57 million shares, these liquidity levels suggest substantive market attention and depth—another hallmark of potentially actionable consolidation phases.

In summary, the technical setup places CNNX on watch for a new bullish phase should either fundamental news or sector catalysts validate a medium-term re-rating.

Fundamental Analysis

• Revenues reached $17.1 million, demonstrating operational bandwidth across a diversified portfolio in Illinois, Massachusetts, and Washington.
• Adjusted EBITDA came in at $1.0 million, a testament to continued progress on cost containment and margin discipline, especially notable against historical high-cash-burn periods.
• In the core markets, wholesale revenues in Massachusetts surged 56% quarter-over-quarter, while Washington rebounded to record highs; these trends highlight the company’s strategic responsiveness to evolving demand patterns.

While net losses persist (precluding a P/E ratio) and the balance sheet remains leveraged (total debt of $68.9 million against a $3.42 to $4.58 million market cap), assets totaling $278.1 million versus liabilities of $326.5 million reflect a capital structure under transition—a profile typical of emerging leaders at a cyclical nadir. Importantly, the engagement of Canaccord Genuity underscores management’s proactive stance toward both capital optimization and fresh funding channels.

Valuation-wise, the current price-to-sales metric is deeply discounted relative to the company’s footprint and growth optionality. With no dividend payout and a beta of 1.18, the stock remains a high-volatility but high-upside instrument, particularly for investors adept at navigating early-stage growth cycles.

Critically, CNNX’s systematically deployed innovations—such as the “Smoke Breaks” brand launch and the introduction of high-velocity products like Koko Gemz edibles and 1988 Infused Blunts—underscore a prowess for rapid response to evolving consumer preferences. The company’s vertically integrated, multistate platform (spanning cultivation, production, and retail) further insulates its margins and market share against transient headwinds, setting a foundation for long-term value accretion.

Volume and Liquidity

Liquidity remains a central strength supporting CNNX’s current valuation and future upside. With an average daily trading volume of 1.57 million shares, the stock exhibits consistent market interest even during volatility, enabling both institutional and retail market participants to execute positions with confidence.

A relatively tight public float, coupled with robust turnover, supports dynamic valuation moves and enhances CNNX’s ability to attract price discovery on incremental news events. This liquidity feature is particularly advantageous in the Canadian marketplace, where U.S.-listed cannabis names have historically been susceptible to thinly traded conditions.

In practical terms, ongoing healthy trading activity both reflects and reinforces investor confidence in the company’s ultimate turnaround and growth proposition.

Catalysts and Positive Outlook

• Facility Expansion: The projected ramp-up in cultivation capacity at Matteson (from 24,000 to 34,800 square feet by January 2025, with subsequent biomass yields exceeding 3,000 pounds monthly) lays the groundwork for material revenue and margin accretion.
• Product Innovation Pipeline: Steady launches of differentiated products across vape, edible, and pre-roll categories enhance shelf space, drive repeat purchases, and build the company into a brand of choice in competitive state markets.
• Strategic Capital Optimization: Engagement with Canaccord Genuity opens the door to recapitalization and new growth funding—a critical lever to accelerate expansion or to fund bolt-on acquisitions as the regulatory environment shifts.
• Regulation and Sentiment: Potential U.S. federal reform (including developments around SAFE Banking, rescheduling, or further state legalizations) could unlock downstream valuation rerating, particularly for operators with established infrastructure and compliance protocols like CNNX.
• ESG and Compliance Credentials: With an experienced management team and a demonstrated track record of navigating shifting legal and operational landscapes, the company is well-positioned to become a beneficiary of responsible investing flows as institutional mandates evolve.

Against a backdrop of sector-wide normalization and the stabilization of competitive pressures in core retail markets, CNNX’s multi-pronged strategy appears well calibrated to outpace less agile peers, opening windows for fundamental revaluation as milestones are met.

Investment Strategies

• Short-term: The combination of deeply oversold technical indicators (RSI ~37), strong historical support, and robust trading volumes may provide nimble traders with a timely entry ahead of potential reversal patterns or near-term news flow (such as production milestone updates or financial announcements).
• Medium-term: For investors with a several-quarter horizon, the company’s roadmap of scaling cultivation, wholesale market expansion (notably in Massachusetts and Illinois), and an imminent wave of new product rollouts set the stage for material improvements in operating leverage and market share. Initiating positions at or near the current lows may offer compelling risk-return asymmetry as valuation multiples revert alongside execution progress.
• Long-term: For those with a strategic outlook aligned to the cannabis sector’s maturation, CNNX’s vertically integrated business model, expanding innovation engine, and growing multi-state platform constitute enduring advantages. As U.S. regulatory dynamics evolve, early positioning in structurally sound, high-asset operators has historically yielded outsize upside, even in the face of episodic volatility.

In all scenarios, discipline, ongoing monitoring, and effective risk management are essential—yet the convergence of low share price, anticipated operational milestones, and sector-wide tailwinds set up CNNX as a candidate for accumulation ahead of potential rerating catalysts.

Is it the Right Time to Buy CNNX?

CNNX is demonstrating a rare confluence of favorable entry characteristics: technically oversold with compelling support levels; fundamentally strengthened by operational execution and innovation; and strategically aligned to capitalize on both sector recovery and company-specific growth initiatives. While financial risks and structural challenges remain—typical of emerging industries at pivot points—these factors appear increasingly priced in at current levels.

With regulatory reform on the horizon, operational expansion ramping up, and a renewed focus on capital optimization, CNNX seems poised to capture meaningful upside in 2025 and beyond. The fundamentals, valuation, and technical landscape justify serious consideration from investors seeking exposure to a high-conviction cannabis growth story at a potentially transformative stage.

For investors ready to position themselves ahead of sector normalization and company-specific catalysts, CNNX may indeed represent an excellent opportunity—combining high risk with the promise of high reward, in a stock where the next bullish phase could be closer than many realize.

As North American cannabis markets continue to evolve, those looking for outsized gains should not overlook the emerging strengths and renewed momentum now characterizing CNNX’s investment case.

How to buy CNNX stock in Canada?

Buying CNNX (now trading as FFNT) stock online is straightforward and secure when done through a regulated Canadian broker. Investors typically choose between two main methods: buying the shares outright (spot or cash purchase) for long-term holding, or trading price movements via CFDs (Contracts for Difference), which is more suited to active traders. Both approaches are accessible from your computer or smartphone and protect your transactions through established regulatory frameworks. To help you select the best platform for your needs, you’ll find a detailed broker comparison further down this page.

Spot buying

A cash or spot purchase means you buy actual CNNX (FFNT) shares through your brokerage account, making you a direct shareholder and allowing you to benefit from any future price appreciation or dividend payments. For Canadian retail investors, fees typically involve a fixed commission per trade—ranging from $4.95 to $9.95 CAD per order—plus a small transaction levy.

Important example

Example:
If the CNNX share price is $0.40 CAD, a $1,000 investment (including a $5 brokerage fee) allows you to purchase about 2,487 shares.

• Gain scenario:
  Should the share price rise by 10%, your shares are now worth $1,100.
  Result: +$100 gross gain, which is a 10% return on your investment.

Trading via CFD

CFD trading lets you speculate on CNNX (FFNT) share price movements without owning the underlying shares. Instead, you enter into a contract with your broker to exchange the difference in price from when you open to when you close the position. CFD trading typically involves a spread (the broker’s markup on the price) and, if you keep the position overnight, an additional financing charge.

Important example

Example:
You start with a $1,000 deposit, trading CNNX via CFDs with 5× leverage. Your market exposure is now $5,000.

• Gain scenario:
  If the stock rises by 8%, your CFD position gains 8% × 5 = 40%.
  Result: +$400 gain on a $1,000 initial outlay (excluding fees).

Final advice

Before investing, always compare brokers for fees, trading platforms, and regulatory protections, using the comparator featured further down this page. Whether you choose direct share ownership or leveraged CFD trading will depend on your personal objectives, appetite for risk, and investment horizon. Selecting the right method is all about aligning your approach to your unique financial goals and experience as an investor.

Platforms

Minimum Deposit

Discover

#1

Tier 1 regulation, including ASIC and FSA

#1

Star Trader

4.9

Minimum Deposit

$50

Discover

with our partner Star Trader

#2

Broker specializing in Forex and CFDs

#2

IFC Markets

4.8

Minimum Deposit

$1

Discover

with our partner IFC Markets

#3

Broker regulated since 2006

#3

Avatrade

4.8

Minimum Deposit

$100

Discover

with our partner Avatrade

Our 7 tips for buying CNNX stock

The latest news about CNNX

4Front Ventures Corp. (formerly CNNX) maintains its primary public listing on the Canadian Securities Exchange (CSE: FFNT), ensuring easy access for Canadian investors and ongoing engagement with regulatory standards applicable in Canada. The company's continued dual listing in Canada and the U.S. underscores its commitment to transparency and cross-border investor engagement, a crucial factor for Canadian market participants seeking exposure to the U.S. cannabis sector. Recent communications confirm compliance with CSE requirements and highlight the company's willingness to work within the evolving Canadian regulatory landscape for cannabis-related equities, which can influence liquidity and investor sentiment in Canada.

The launch of 4Front's new "Smoke Breaks" brand and expanded product lines in Illinois and Massachusetts support the company's competitive product positioning, with potential positive ripple effects for Canadian investors monitoring innovation as a growth driver. This wave of product innovation—inclusive of new SKUs for edibles, concentrates, vapes, and pre-rolls—reflects 4Front's strategy to capture a larger share of expanding U.S. legal cannabis markets. For the Canadian context, these initiatives provide a benchmark for product and marketing approaches that could inform, or eventually be transplanted into, Canadian retail environments should cross-border business opportunities and regulatory harmonization progress.

The ongoing expansion of the Matteson, Illinois cultivation and production facility, targeting a more than 40% increase in cultivation space by mid-January 2025, signals near-term operational scale-up with long-term growth implications. This operational development is poised to elevate monthly biomass yields to over 3,000 pounds, reinforcing capacity to meet wholesale and retail demand. Canadian analysts and stakeholders frequently monitor U.S. state-level supply increases as indicators of price discipline, scalability, and potential for innovation transfer—factors that can indirectly shape Canadian cannabis market expectations and corporate strategies.

Q3 2024 financial results exhibited resilience, with total revenues at $17.1 million and significantly improved wholesale growth in Massachusetts, despite quarterly softness in Illinois retail sales. Massachusetts wholesale revenues climbed over 56% quarter-over-quarter, evidencing successful channel diversification and demand capture, while the Washington market returned to record revenue levels. Balanced against modest Adjusted EBITDA and a persistent net loss, these results point to constructive operating momentum, which Canadian analysts may view as an indicator of management expertise and the possibility for sustained, scale-driven financial improvements relevant to investors in both jurisdictions.

Technical indicators, notably the 14-day RSI at 37 and a slightly negative MACD, suggest the stock is in oversold territory, potentially offering a tactical entry point as operational improvements take effect. While not a guarantee of immediate upside, these signals, combined with a neutral-to-cautious fundamental sentiment, indicate that 4Front shares could attract Canadian value or speculative investors anticipating a rebound, especially as the impact of ongoing strategic initiatives materializes and broader cannabis sector sentiment stabilizes.

FAQ

P. Laurore

Finance expert

Co-founder of HelloSafe and holder of a Master's degree in finance, Pauline has recognised expertise in personal finance, which she uses to help users better understand and optimise their financial choices. At HelloSafe, Pauline plays a key role in designing clear, educational content on savings, investments and personal finance. Passionate about financial education, Pauline strives, with every piece of content she oversees, to provide reliable, transparent and unbiased information for independent and informed financial management. To this end, she has tested over 100 trading platforms to help internet users make the right choices.